Kiersten W. Ricci, MD
- Clinical Director, Hemangioma & Vascular Malformation Program
- Medical Fellowship Director, Hemangioma & Vascular Malformation Program
- Member, Division of Hematology, Cancer and Blood Diseases Institute
- hvmc@cchmc.org
- Board Certified
About
MD: The Ohio State University College of Medicine, Columbus, OH, 2006-2010.
Residency: Pediatrics, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, 2010-2013.
Fellowship: Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2013-2016.
Chief Fellow: Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2015-2016.
Board Certifications: Pediatrics, 2013-current; Pediatric Hematology/Oncology, 2017-current.
Interests
Blood disorders; thrombosis; coagulopathy; infantile and congenital hemangiomas; vascular malformations; non-malignant vascular tumors
Services and Specialties
Hemangioma and Vascular Malformations, Cancer and Blood Diseases, Sturge-Weber Syndrome, Rare Lung Diseases
Interests
Vascular malformations; non-malignant vascular tumors; complex lymphatic anomalies; coagulopathy and thrombosis in vascular anomalies; hemangiomas; clinical trials and translational research studies
Research Areas
Hematology
Locations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
How we use angiopoietin-2 in the diagnosis and management of vascular anomalies. Pediatric Blood and Cancer. 2024; 71:e30921.
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatric Blood and Cancer. 2024; 71:e30779.
Medical Management and Therapeutic Updates on Vascular Anomalies of the Head and Neck: Part 2. Oral and Maxillofacial Surgery Clinics of North America. 2024; 36:115-123.
Medical Management of Nonmalignant Vascular Tumors of the Head and Neck: Part 1. Oral and Maxillofacial Surgery Clinics of North America. 2024; 36:103-113.
Medical Therapeutics for the Treatment of Vascular Anomalies: Part 3. Oral and Maxillofacial Surgery Clinics of North America. 2024; 36:125-136.
Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatric Blood and Cancer. 2023; 70:e30215.
How we approach the diagnosis and management of complex lymphatic anomalies. Pediatric Blood and Cancer. 2022; 69 Suppl 3:e28985.
Total pancreatectomy with islet autotransplantation in a child with pancreatic kaposiform hemangioendothelioma. Journal of Pediatric Surgery Case Reports. 2022; 81:102266.
Diagnostic Considerations in H1N1 Influenza-induced Thrombotic Microangiopathy. Journal of Pediatric Hematology/Oncology. 2022; 44:e237-e240.
Metastatic neuroblastoma masquerading as infantile hemangioma in a 4-month-old child. Pediatric Blood and Cancer. 2021; 68:e28920.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey